Tacroz Ointment is used to treat eczema (atopic dermatitis). It works by suppressing the activity of certain immune cells that cause inflammation (redness and swelling) of the skin. This relieves itching and improves rashes in atopic dermatitis.
1.Anti-Inflammatory: Tacroz ointment has potent anti-inflammatory properties, making it effective in managing inflammatory skin conditions.
2.Immunosuppressive: It suppresses the immune system’s activity in the skin, reducing immune responses that contribute to skin disorders.
3.Topical Treatment: Suitable for localised skin conditions, providing targeted relief.
1.Tacrolimus 0.03%: The active ingredient, belonging to the calcineurin inhibitor class, known for its immunosuppressive and anti-inflammatory properties.
2.Excipients: Additional ingredients may be present to enhance the formulation and stability of the ointment.
Warnings Of Tacroz 0.03% Ointment:
1.Avoid Sun Exposure: Patients are advised to avoid prolonged sun exposure, as Tacrolimus may increase sensitivity to sunlight.
2.Not for Open Wounds: It is not recommended for use on open wounds or broken skin.
3.Consultation with Dermatologist: Before use, consultation with a dermatologist is essential, especially for individuals with a history of skin cancer.
Usage Of Tacroz 0.03% Ointment:
1.Prescription-Only: Tacroz 0.03 ointment is a prescription medication, and its use should be directed by a healthcare professional.
2.Thin Layer Application: Applied in a thin layer to the affected area, usually twice daily.
3.Wash Hands After Application: Hands should be washed thoroughly after applying the ointment unless the hands are the treated area.
Side Effects Of Tacroz 0.03% Ointment:
1.Burning or Itching Sensation: Some patients may experience a mild burning or itching sensation at the application site.
2.Redness: Temporary redness at the application site is a common side effect.
3.Skin Atrophy: Prolonged use may lead to skin atrophy in some cases.
Safety Information Of Tacroz 0.03% Ointment:
1.Pregnancy and Lactation: Pregnant or breastfeeding women should consult with their healthcare provider before using Tacroz.
2.Pediatric Use: Safety and efficacy in paediatric patients should be carefully evaluated, and usage should be as per the healthcare provider's recommendation.
3.Long-Term Use: Prolonged use should be under the supervision of a dermatologist, considering potential risks and benefits.
Note: It is essential to read and follow the instructions provided with the specific brand or formulation of Tacroz 0.03% Ointment and consult a dermatologist or healthcare professional for personalised advice regarding its use in dermatology.
Marketer details
Name: Glenmark Pharmaceuticals Ltd
Address: Glenmark Pharmaceuticals Limited, B/2, Mahalaxmi Chambers, 22, Bhulabhai Desai Road, Mumbai – 400 026.
Country of origin: India
Expires on or after: October, 2026